Aurora Cannabis

Five of the Biggest Cannabis Company Earnings to Know

Retrieved on: 
Thursday, May 16, 2019
Entheogens, Cannabis, Articles, Health, Tilray, Aurora Cannabis, Cannabis and religion, OTC Markets Group

PALM BEACH, Florida, May 16, 2019 /PRNewswire/ -- After nearly a full quarter of recreational cannabis sales in Canada, the world's cannabis producers are posting earnings.

Key Points: 
  • PALM BEACH, Florida, May 16, 2019 /PRNewswire/ -- After nearly a full quarter of recreational cannabis sales in Canada, the world's cannabis producers are posting earnings.
  • While some earnings weren't as great as hoped, others did very well.Top companies releasing earnings included Lifestyle Delivery Systems Inc. (CSE:LDS)(OTC:LDSYF), Tilray Inc. (NASDAQ:TLRY), Aurora Cannabis Inc. (NYSE:ACB)(TSX:ACB), CannTrust Holdings Inc. (NYSE:CTST)(TSX:TRST) and The Supreme Cannabis Company Inc. (TSX:FIRE)(OTC:SPRWF).
  • "I'm exceptionally proud of our company and team as Aurora continues to deliver on our domestic and international growth strategy.
  • The Supreme Cannabis Company Inc. (TSX:FIRE)(OTCQX:SPRWF) announced its financial and operating results for the three and nine months ended March 31, 2019.

Cannabis Europa Announces Aurora as Headline Sponsor

Retrieved on: 
Tuesday, May 14, 2019
Cannabis smoking, Entheogens, Euphoriants, Medicinal plants, Cannabis, Psychoactive drugs, Plants, Herbs, Effects of cannabis, Aurora Cannabis

LONDON, May 14, 2019 /PRNewswire/ -- Cannabis Europa has officially announced the signing of world-leading Canadian medical cannabis company Aurora (ACB) as headline sponsor for the upcoming event, taking place at London's Southbank Centre on June 24th and 25th.

Key Points: 
  • LONDON, May 14, 2019 /PRNewswire/ -- Cannabis Europa has officially announced the signing of world-leading Canadian medical cannabis company Aurora (ACB) as headline sponsor for the upcoming event, taking place at London's Southbank Centre on June 24th and 25th.
  • Aurora Europe, along with its subsidiary Aurora Deutschland, is now the largest authorised importer, exporter, and distributor of EU-GMP certified medical cannabis in the European Union.
  • We value our partnership with Cannabis Europa, and will continue to nurture the growth of the European cannabis market together."
  • Aurora Europe, along with its subsidiary Aurora Deustchland, is now the largest authorised importer, exporter, and distributor of EU-GMP certified medical cannabis in the European Union.

Cannabis Europa Announces Aurora as Headline Sponsor

Retrieved on: 
Tuesday, May 14, 2019
Cannabis smoking, Entheogens, Euphoriants, Medicinal plants, Cannabis, Psychoactive drugs, Plants, Herbs, Effects of cannabis, Aurora Cannabis

LONDON, May 14, 2019 /PRNewswire/ -- Cannabis Europa has officially announced the signing of world-leading Canadian medical cannabis company Aurora (ACB) as headline sponsor for the upcoming event, taking place at London's Southbank Centre on June 24th and 25th.

Key Points: 
  • LONDON, May 14, 2019 /PRNewswire/ -- Cannabis Europa has officially announced the signing of world-leading Canadian medical cannabis company Aurora (ACB) as headline sponsor for the upcoming event, taking place at London's Southbank Centre on June 24th and 25th.
  • Aurora Europe, along with its subsidiary Aurora Deutschland, is now the largest authorised importer, exporter, and distributor of EU-GMP certified medical cannabis in the European Union.
  • We value our partnership with Cannabis Europa, and will continue to nurture the growth of the European cannabis market together."
  • Aurora Europe, along with its subsidiary Aurora Deustchland, is now the largest authorised importer, exporter, and distributor of EU-GMP certified medical cannabis in the European Union.

EMMAC to Import Cannabis Products into Germany; Supply Agreement with CC Pharma

Retrieved on: 
Tuesday, May 14, 2019
Health, Alternative medicine, Biotechnology, Pharmaceutical, Health, Pharmaceutical industry in China, Pharmaceuticals policy, Pharmacy in China, Science and technology in the People's Republic of China, Cannabis, Pharmaceutical industry in India, Medicine, Aurora Cannabis

Working in conjunction with Medalchemy, EMMACs fully-licensed GMP certified laboratory and research and development facility in Spain, About Nature has entered into a supply agreement (the Agreement) with CC Pharma GmbH (CC Pharma), a leading importer and distributor of EU-pharmaceuticals for the German market.

Key Points: 
  • Working in conjunction with Medalchemy, EMMACs fully-licensed GMP certified laboratory and research and development facility in Spain, About Nature has entered into a supply agreement (the Agreement) with CC Pharma GmbH (CC Pharma), a leading importer and distributor of EU-pharmaceuticals for the German market.
  • The Agreement allows EMMAC to import high-quality dried cannabis flowers and oils into the rapidly expanding German market, which is the largest medical cannabis market in Europe.
  • Antonio Costanzo, CEO of EMMAC, commented: The decision by CC Pharma to distribute EMMAC medical cannabis product in Germany validates our commitment to delivering the highest quality product and we are delighted to announce the Agreement today.
  • CC Pharma is a leading importer and distributor of EU-pharmaceuticals for the German market and distributes products to over 13,000 German pharmacies.

Aurora Cannabis and Radient Technologies Announce First Commercial Delivery of Cannabis Derivatives

Retrieved on: 
Monday, May 13, 2019
Cannabis, Aurora Cannabis, Cannabis in British Columbia, Aurora, Illinois, Aurora

EDMONTON, May 13, 2019 /PRNewswire/ -Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE:ACB) (TSX: ACB) (Frankfurt: 21P; WKN: A1C4WM) and Radient Technologies Inc. ("Radient") (TSX Venture: RTI; OTCQX: RDDTF), announced today that Aurora has taken delivery of Radient's first commercial batch of finished cannabis derivatives, fromRadient's proprietary extraction platform.

Key Points: 
  • EDMONTON, May 13, 2019 /PRNewswire/ -Aurora Cannabis Inc. (the "Company" or "Aurora") (NYSE:ACB) (TSX: ACB) (Frankfurt: 21P; WKN: A1C4WM) and Radient Technologies Inc. ("Radient") (TSX Venture: RTI; OTCQX: RDDTF), announced today that Aurora has taken delivery of Radient's first commercial batch of finished cannabis derivatives, fromRadient's proprietary extraction platform.
  • The partnership between Radient and Aurora was established in 2017 after the completion of a Research Joint Venture thatvalidatedRadient's MAPTMextraction technology was capable of superior cannabinoid extraction at commercial scale.
  • For Aurora, the relationship with Radient forms an important component of its derivative product strategy,providinga greater return on the biomass allocatedfor extraction,favourablecost advantages, and significantly increasedextraction capacity.
  • "Aurorarecognized earlythat high-throughput, high-quality extraction technologies would be acompetitive advantage in a rapidly developing cannabis industry," said Terry Booth, CEO of Aurora.

The Cannabis Council of Canada announces newly elected Board of Directors

Retrieved on: 
Thursday, May 9, 2019
Cannabis, Aurora Cannabis, Cannabis in British Columbia, Medicine

OTTAWA, May 9, 2019 /CNW/ - After a very successful first year as a unified national industry association, and with the framework of cannabis legalization firmly established, the Cannabis Council of Canada ("C3") is pleased to announce its newly elected Board of Directors (the "Board").

Key Points: 
  • OTTAWA, May 9, 2019 /CNW/ - After a very successful first year as a unified national industry association, and with the framework of cannabis legalization firmly established, the Cannabis Council of Canada ("C3") is pleased to announce its newly elected Board of Directors (the "Board").
  • C3's general membership represents almost 90% of Canada's legal cannabis industry, and has elected the following individuals to the Board:
    John Fowler The Supreme Cannabis Company, Vice Chair, Adult Use
    Darren Karasiuk Aurora Cannabis Inc.
    Alison Gordon 48 North Cannabis Co.
    Gerald Proctor Sundial Growers Inc.
  • In my first year as a board member, I saw the tremendous impact that C3 has made on this industry.
  • The Board also announces the departure of its Executive Director, Allan Rewak, who will be leaving C3 to join Emerald Health Therapeutics.

Aurora Cannabis Extends Exclusive Supply Relationship with Luxembourg

Retrieved on: 
Thursday, May 9, 2019
Health, Articles, Entheogens, Medicinal plants, Cannabis, Aurora Cannabis, Cannabis in British Columbia, Cannabis culture, Legality of cannabis, Aurora, Illinois, Medical cannabis

EDMONTON, May 9, 2019 /PRNewswire/ -Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (NYSE: ACB) (Frankfurt: 21P; WKN: A1C4WM) announced today that the Company, through its wholly owned subsidiary Aurora Deutschland, has been selected by the Luxembourg Health Ministry as the exclusive supplier in a public bid to supply a second delivery of medical cannabis to Luxembourg.

Key Points: 
  • EDMONTON, May 9, 2019 /PRNewswire/ -Aurora Cannabis Inc. ("Aurora" or the "Company") (TSX: ACB) (NYSE: ACB) (Frankfurt: 21P; WKN: A1C4WM) announced today that the Company, through its wholly owned subsidiary Aurora Deutschland, has been selected by the Luxembourg Health Ministry as the exclusive supplier in a public bid to supply a second delivery of medical cannabis to Luxembourg.
  • "We are proud to continue serving as the exclusive supplier of medical cannabis to the Luxembourg Health Ministry," said Neil Belot, Chief Global Business Development Officer.
  • We're proud of our teams' achievements to date and look forward to supplying patients in Luxembourg with improved access to high quality medical cannabis."
  • EU GMP certification has been granted to Aurora's first production facility in Mountain View County, the MedReleaf Markham facility, and its wholly owned European medical cannabis distributor Aurora Deutschland.

Supreme Cannabis Third Quarter Earnings Release Scheduled for May 13, 2019

Retrieved on: 
Monday, May 6, 2019
Cannabis, Cannabis smoking, Entheogens, Euphoriants, Drugs, OTC Markets Group, Legality of cannabis, Medicine, Aurora Cannabis, Canopy Growth

TORONTO, May 6, 2019 /PRNewswire/ - The Supreme Cannabis Company, Inc. ("Supreme Cannabis" or the "Company") (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) today announced that it will be providing its third quarter financial results for the three and nine months ended March 31, 2019 after markets close on May 13, 2019.

Key Points: 
  • TORONTO, May 6, 2019 /PRNewswire/ - The Supreme Cannabis Company, Inc. ("Supreme Cannabis" or the "Company") (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) today announced that it will be providing its third quarter financial results for the three and nine months ended March 31, 2019 after markets close on May 13, 2019.
  • The Supreme Cannabis Company, Inc. , is a global diversified portfolio of distinct cannabis companies, products and brands.
  • Certain statements made in this press release may constitute forward-looking information under applicable securities laws.
  • View original content to download multimedia: http://www.prnewswire.com/news-releases/supreme-cannabis-third-quarter-e...
    SOURCE The Supreme Cannabis Company, Inc.

Aurora Cannabis Provides Construction Update on Aurora Sun

Retrieved on: 
Wednesday, April 10, 2019
Medicinal plants, Medicine, Herbalism, Entheogens, Euphoriants, Health sciences, Health, Antioxidants, Medical cannabis, Aurora, Illinois, Cannabis, Aurora Cannabis

With the Sky Class production philosophy proven at Aurora Sky, the Company is confident in projecting an expected production capacity at Aurora Sun in excess of 230,000 kg of high-quality cannabis per annum.

Key Points: 
  • With the Sky Class production philosophy proven at Aurora Sky, the Company is confident in projecting an expected production capacity at Aurora Sun in excess of 230,000 kg of high-quality cannabis per annum.
  • They are not greenhouses, but purpose-built, indoor cannabis grow facilities that create the most optimal growing conditions for cannabis.
  • "Aurora Sun represents the next evolution in our Sky Class facility design, delivering massive scale, low cost production, and consistent, high-quality cannabis," said Terry Booth, CEO of Aurora.
  • Like Aurora Sky, Health Canada licensing requests have determined that rooms will be available for planting before the entire facility is completed.

Aurora Cannabis Awarded Maximum Number of Lots in German Cannabis Production Tender

Retrieved on: 
Friday, April 5, 2019
Medicinal plants, Entheogens, Euphoriants, Medicine, Herbalism, Health sciences, Health, Drug control law, Cannabis, Legality of cannabis, Medical cannabis, Aurora Cannabis

The Company was awarded the maximum number of 5 of the 13 lots in the tender over a period of four years with a minimum supply of 4000kg total.

Key Points: 
  • The Company was awarded the maximum number of 5 of the 13 lots in the tender over a period of four years with a minimum supply of 4000kg total.
  • The cannabis produced will be sold to the German government and supplied to wholesalers for distribution to pharmacies.
  • We commenced delivering dried cannabis flower from Canada to the German market in 2017, and recently added cannabis extracts to our offerings for German patients.
  • Upon finalization of the allotment we will commence with our project to construct a state-of-the-art cannabis production facility to further service German patients with safe, high-quality cannabis."